(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 5.88% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Sotera Health Co's revenue in 2025 is $1,106,788,000.On average, 9 Wall Street analysts forecast SHC's revenue for 2025 to be $331,826,581,506, with the lowest SHC revenue forecast at $320,472,378,546, and the highest SHC revenue forecast at $346,303,190,280. On average, 9 Wall Street analysts forecast SHC's revenue for 2026 to be $351,696,436,686, with the lowest SHC revenue forecast at $338,922,958,356, and the highest SHC revenue forecast at $369,579,306,348.
In 2027, SHC is forecast to generate $373,269,422,310 in revenue, with the lowest revenue forecast at $358,508,958,462 and the highest revenue forecast at $393,139,277,490.